TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Uscom Limited ( (AU:UCM) ) has issued an announcement.
Uscom Limited reported a 5% decline in revenue and other income for the half-year ending December 31, 2024, totaling $1,859,295. The company’s net loss attributable to members increased by 32% to $1,188,595, and no dividend is proposed. The financial results highlight challenges in maintaining revenue levels and managing operational losses, impacting its financial position and potentially influencing stakeholder confidence.
More about Uscom Limited
Uscom Limited operates in the medical technology industry, focusing on the development and distribution of advanced cardiovascular and pulmonary medical devices. The company is known for its innovative solutions aimed at improving patient care and outcomes in the healthcare sector.
YTD Price Performance: -23.33%
Average Trading Volume: 84,307
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: A$5.76M
Find detailed analytics on UCM stock on TipRanks’ Stock Analysis page.